Press release content from Globe Newswire. The AP news staff was not involved in its creation.
CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares
CollPlant BiotechnologiesFebruary 12, 2021 GMT
REHOVOT, Israel, Feb. 11, 2021 (GLOBE NEWSWIRE) CollPlant Biotechnologies (NASDAQ:CLGN), today announced that it has entered into definitive agreements with several healthcare-focused and other institutional investors for the purchase and sale of 2,000,000 of the Company’s American Depositary Shares (ADSs), at a purchase price of $17.50 per ADS, in a registered direct offering. Each ADS represents one (1) ordinary share, par value NIS 1.50 per share, of CollPlant. The offering is expected to close on or about February 17, 2021, subject to satisfaction of customary closing conditions.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Future FinTech and China Foundation of Consumer Protection Enter Into Cooperation Agreement to Use Blockchain Technology Against Counterfeit Products
February 12, 2021 GMT
NEW YORK, Feb. 12, 2021 /PRNewswire/ Future FinTech Group Inc. (NASDAQ: FTFT) (“Future FinTech”, “FTFT” or “Company”), a leading blockchain based e-commerce business and a fintech service provider, announced today that, its wholly-owned subsidiary Chain Cloud Mall Network and Technology (Tianjin) Co., Limited (“CCM”) has signed a cooperation agreement with The Merchandise and Quality Week Magazine, a news magazine directly owned by China Foundation of Consumer Protection. The cooperation has a term for five years, from February 1, 2021 to January 31, 2026. The Anti-Counterfeiting Committee of China Foundation of Consumer Protection will set up a “Quality and Safety Office” and appoint Mr. Zhi Yan, th
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China .
Apollomics, Inc.February 12, 2021 GMT
FOSTER CITY, Calif. and HANGZHOU, ZHEJIANG, China, Feb. 12, 2021 (GLOBE NEWSWIRE) Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced an exclusive license agreement for the development and commercialization of TYG100 in Mainland China, Hong Kong, Macau and Taiwan, also known as Greater China, and South Africa.
TYG100 is an antigen-specific, active checkpoint control immunotherapy (ACCI) recombinant vaccine comprising the amino-terminal sequence of G17, a gastrointestinal peptide hormone, and utilizes the S-TIR™ technology platform. This technology induces a novel mechanism of action that is able to unmask tumors. TYG100 was developed by T
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Sigma Lithium Announces Closing of C$42.0 million Private Placement of Common Shares
Sigma Lithium Resources CorporationFebruary 12, 2021 GMT
The Offering book was oversubscribed and comprised primarily of the current shareholders of the Company: global ESG-oriented institutional investors focused on the theme of battery materials & energy transition
The Offering proceeds will be used to advance Phase 2 of Sigma’s Grota do Cirilo Project and enhance the Company’s financial flexibility during the construction of Phase 1 of the Project
VANCOUVER, British Columbia, Feb. 12, 2021 (GLOBE NEWSWIRE) SIGMA Lithium Resources Corporation (“Sigma” or the “Company”) (TSXV: SGMA) (OTC-QB: SGMLF) is pleased to announce that it has closed its previously announced upsized non-brokered private placement of common shares (the “Offering”) and has issued 9,545,455 common shares at a pric